Drug seminar focuses on economies of biosimilars

Published: 2009-11-20 07:00:00

Updated: 2009-11-20 07:00:00

The economics of biologics will grow more challenging, especially as demand increases as the financial model of the industry has been built on aggressive pricing of drugs intended for use in a limited number of patients, according a local consultant.

In a pharmaceutical seminar on November 18,...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK